Mirae Asset Global ETFs Holdings’s SpyGlass Pharma SGP Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SGP Stock Details SGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114K	Buy	+5,103	New	+$111K	﹤0.01%	2756

Other funds holding SGP

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's SGP Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in SpyGlass Pharma (SGP) in Q2 2026: 5,103 shares worth $114K. The stake represents ﹤0.01% of the portfolio and ranks #2756 among its holdings.

43 funds tracked by Wall St. Rank hold SGP as of Q2 2026.

Mirae Asset Global ETFs Holdings held 5,103 shares of SpyGlass Pharma worth $114K as of Q2 2026.
SpyGlass Pharma was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
SpyGlass Pharma made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2756 holding.
43 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.